Propel a Cure for Crohn’s Disease
@propelacure
Followers
1K
Following
12K
Media
606
Statuses
3K
We help fund scientists in the quest to uncover the causes of Crohn's disease, with the goal of cures. We are an all-volunteer, tax-exempt 501(c) (3) nonprofit.
Worldwide
Joined May 2018
Thank you for such a thoughtful discussion, Amber! Watch the full video episode here:
🧐 Curious about IBD research? On #AboutIBDPodcast, I talk with @propelacure president & CEO, Angela Clark. Propel a Cure funds research into the causes of #Crohns. Listen in any podcast app, see a video on YouTube, or use my website to choose either: https://t.co/JKWh5CL5Cr
0
2
4
❌Avoid fiber in #IBD ✅Choose the right fiber type and texture 💡Fiber matters in IBD, and we want to share with you what the latest science says on how to add it safely: 👉 What works well during remission might not be tolerated during a flare 👉 Which fiber type is better
1
10
22
Our Fall newsletter is dropping soon! 🚀 Sign up today at https://t.co/OjhP9Y3ANi for exclusive content and all the latest research updates straight to your inbox. #ibdawareness #crohnsdisease #crohns #ibd
0
2
2
This is great «Mistakes in» article by Rosana and Nuru on newly diagnosed Crohn’s Check it out! ☄️ @my_ueg @aegastro @sepdigestiva @ibdseb @fgomollon @OPGEgastro @pancco_org
In our new article, "Mistakes in newly diagnosed Crohn's disease", @RoseiraJoana and Nurulamin Noor highlight frequent errors in the early management of CD — from delayed diagnosis to undertreatment — and share practical strategies to improve care. 🔗 https://t.co/zxlh1Wiz2H
2
6
17
🔬New Research Opportunity Propel a Cure partners with Rare Patient Voice to connect patients and caregivers with research studies. Together, we’re helping make sure diverse voices are represented in important research. 📋 Study Details: - Who: African American or Hispanic
0
3
9
Junctional plakoglobin in the intestinal epithelium, which is lost in #Crohns patients, modulates a crosstalk between intestinal epithelium and the immune system: https://t.co/eF4kRXPImv
0
6
24
August is Short Bowel Syndrome Awareness Month. SBS is a serious complication that some Crohn’s patients face, drastically affecting nutrition, energy, and daily life. For many, it means relying on IV nutrition or fighting each day to maintain strength. At Propel a Cure, we
0
2
8
“Why do we need new targets for Crohn’s therapies?“ In this 1 Minute Inside IBD, the Promakhos Therapeutics team explains: ✨ Current drugs have hit their ceiling of efficacy ✨ There’s an upstream problem driving disease ✨ The real goal is restoring the innate immune system
3
6
29
#IBD in kids isn’t always easy to see. Little ones may not have the words, teens may stay quiet out of embarrassment, and even doctors can miss slowed growth or delayed puberty. Early recognition is key so kids can get the care they need to thrive. 🌱 #veoibd #PediatricIBD
0
1
6
Yes diet matters in managing #crohnsdisease. We may not have all the answers yet nor for all patient scenarios. But have a read of our study by the @ibdgc where we identify specific micronutrients that are associated with recurrence after ileal resection surgery. Expertly
3
18
51
🔥🔥🔥🔥Hope Biosciences Research Foundation Opens Enrollment for FDA-Authorized Crohn’s Disease Stem Cell Trial - LET'S GO!!!!!!!!!
businesswire.com
Hope Biosciences Research Foundation (HBRF) today announced the opening of enrollment for a Phase II clinical trial evaluating the potential of intravenously...
1
2
2
🧬 Mild #CrohnsDisease has its own unique biology, per Dr. @ryanungaro & @MountSinaiGI. 🧪 Findings could guide more #PrecisionMedicine & less aggressive care. https://t.co/PZPVopx1jn
healio.com
Mild Crohn’s disease is associated with distinct molecular features, including decreased immune response and alterations in sphingolipid metabolism, according to research published in Gastroenterol...
0
3
11
Nice to see more data on this.
Vitamin D shows potential as adjunct in IBD treatment https://t.co/3PfDb8rPqf
@GoHealio
0
1
7
“What insights beyond risk prediction can studying the preclinical stage of #IBD give us?” In our interview with Dr. Joana Torres, she explains how research studying the preclinical stage of IBD can help map the inflammatory pathways driving disease and even distinguish who may
0
2
8
Science doesn’t need to go according to plan; it just needs to lead to a discovery. If doesn’t have to be done alone or together with a buddy; there just needs to be a discovery. It doesn’t need to happen fast or slow; just as long as there’s a discovery, then everybody is happy.
15
265
1K
"This study is the first comprehensive high-resolution analysis of the exact antigenic nature of systemic antibody responses during the transition from prediagnostic to established #IBD."
Read the #GUTOnline paper by Bourgonje @BourgonjeArno et al on "Crohn’s disease and ulcerative colitis exhibit prediagnostic antibody signatures with shared and divergent changes towards disease onset" via https://t.co/jcRHAV9a4x
@KalkaIris @jingyuan_fu @WeersmaLab #IBD
0
2
11
The PIANO (Pregnancy Inflammatory bowel disease And Neonatal Outcomes) Consensus Group has developed the first Global Consensus on management of pregnancy for patients with inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis. The group is led
The @HelmsleyTrust @PIANOIBD Global Consensus Statement will be in print in early August! Please join @MLongMD and myself for a global webinar to review the recommendations. After the webinar, the slides will be released to the public. Link: https://t.co/HT3s6iKEMv
0
3
12
Your experience can help shape the future of #IBD research! We’ve partnered with Rare Patient Voice to connect patients and caregivers with paid research opportunities—advancing studies on both rare and common chronic conditions, while also supporting Propel a Cure’s mission to
0
2
4
Big news! Our CEO, Angela Clark, was recently featured on the IBD Connect blog. In the interview, Angela shares her personal journey with Crohn’s and how it led her to lead Propel a Cure—a volunteer-run nonprofit focused on bold, early-stage research to uncover the root causes
0
2
18